Important advances in oncology

著者

• DeVita, Vincent T.
• Hellman, Samuel
• Rosenberg, Steven A.

書誌事項

Important advances in oncology

edited by Vincent T. DeVita, Jr., Samuel Hellman, Steven A. Rosenberg

Lippincott, 1985-

• 1985
• 1986
• 1987
• 1988
• 1989
• 1990
• 1991
• 1992
• 1993
• 1994
• 1995
• 1996

注記

1996:Lippicott-Raven Publisher

内容説明・目次

巻冊次

1992 ISBN 9780397511570

内容説明

Discusses the most recent advances in oncology, and provides firsthand reports of the significant progress being made in the field. The contributors are all either personally responsible for these advances or directly involved with their implementation in clinical settings. All the topics are chosen for their timeliness and importance for potential clinical applicability. Identified and carefully presented so that you can, in once source, gain authoritative knowledge of the many new and exciting leads coming from laboratory and clinical research applicable to the cause, prevention, diagnosis and treatment of cancer. This series of text, now in its 8th year, has tracked substantial advances in cancer research. Themes have emerged that carry over from edition to edition. The discovery of oncogenes was followed by the description of their function and now, in this edition, their influence on the control of the cell cycle as it relates to uncontrolled growth. Mechanisms of drug resistance and the development of biologics as therapeutics, as well as the advances in the adjuvant therapy of cancer have appeared in different forms through several editions. This year biologic therapy has advanced to gene therapy and focus is now on a different form of multidrug resistance related to topoisomerase-drug interactions.

目次

• Part 1 Basic science: the biochemical nature of the cell cycle
• gene therapy of cancer
• perfluorochemical emulsions/oxygen breathing in radiation sensitization and chemotherapy modulation
• pancreatic antigens
• topoisomerase-targeting antitumour drugs - mechanisms of cytotoxicity and resistance. Part 2 Clinical: retinoid chemoprevention of upper aerodigestive tract carcinogenesis
• immunotoxin therapy of malignancy
• continent urinary diversion
• the use of combination chemotherapy in the treatment of early stage Hodgkin's Disease
• use of intraoperative ultrasound during cancer surgery
• quality of life measurements in cancer treatment. Part 3 Controversies: is hepatic infusion chemotherapy effective treatment for liver metastases?
• is meta-analysis a valuable method for the analysis of clinical trial data?
• yes - meta-analysis of randomized control trials applied to cancer therapy
• no - quo vadis meta-analysis? a potentially dangerous tool if used without adequate rules.

巻冊次

1993 ISBN 9780397513192

内容説明

The most recent advances in oncology, reported by those either personally responsible for them, or directly involved in their implementation. Topics, chosen for timeliness and clinical relevance, are identified and presented so that you can, in one source, explore the many new and exiciting leads coming from laboratory and clinical research applicable to the cause, prevention, diagnosis and treatment of cancer.

目次

• Part 1 Basic science: protein tyrosine kinases, oncogenes and cancer
• programmed cell death - Bcl-2
• fluorescence in situ hybridization in cancer diagnosis
• genetic basis of renal cell cancer
• the role of cytokines in radiation oncology
• retinoic acid and its rearranged receptor in the treatment of acute promyelocytic leukaemia. Part 2 Clinical studies: early diagnosis of prostate cancer
• hormonal manipulation in the adjuvant treatment of breast cancer
• chemotherapy and radiation in the non-operative management of stage III non-small-cell lung cancer - the right chemotherapy works in the right setting
• purging of autologous bone marrow in the treatment of non-Hodgkin's lymphoma
• laparoscopic surgery in cancer treatment
• the use of peripheral stem cell support of high-dose chemotherapy. Part 3 Controversies in oncology: are silicone breast prostheses safe for use in breast reconstruction? yes
• is cyclic chemotherapy better than standard four-drug chemotherapy for Hodgkin's disease? yes
• is alternating cyclic chemotherapy better than standard four-drug chemotherapy for Hodgkin's disease? no.

巻冊次

1994 ISBN 9780397513833

内容説明

This 9th volume, written by leading authorities in the field, provides first-hand reports of the significant progress being made in the field of oncology. The contributors, all of whom are either personally responsible for these advances or directly involved with their implementation in clinical settings, present topics that are timely and important for potential clinical applicability. This book provides authoritative knowledge on the many new leads from laboratories and clinical research that are applicable to the cause, prevention, diagnosis and treatment of cancer.

巻冊次

1995 ISBN 9780397514939

内容説明

Provides reports of progress being made in the field of oncology. This resource provides data from laboratories and clinical research that are applicable to the cause, prevention, diagnosis and treatment of cancer.

巻冊次

1996 ISBN 9780397516018

内容説明

This twelfth volume in the series provides first-hand reports of the progress being made in the field of oncology. Leads from laboratories and clinical research that are applicable to the cause, prevention, diagnosis and treatment of cancer are included.

目次

• Basic science
• clinical applications
• controversies in oncology.

「Nielsen BookData」 より

詳細情報

• NII書誌ID(NCID): BA02829397
• ISBN:
  • 0397506805
  • 0397507526
  • 0397507860
  • 039750893X
  • 0397510047
  • 0397510586
  • 0397511566
  • 0397511574
  • 0397513194
  • 0397513836
  • 039751493X
  • 0397516010
• 出版国コード: us
• タイトル言語コード: eng
• 本文言語コード: eng
• 出版地: Philadelphia
• ページ数/冊数: v.
• 大きさ: 26 cm
• 分類:
  • NLM : W1
• 件名:
  • MESH : Medical Oncology